Special Investigation Of Somavert -Long Term Use-
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Pegvisomant (Primary)
- Indications Acromegaly
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 01 Jan 2021 New trial record
Latest Information Update: 27 Sep 2023